Home > Healthcare > Pharmaceuticals > Finished Drug Form > Demulcent Eye Drops Market

Demulcent Eye Drops Market Share

Report ID: GMI5351
Published Date: Sep 2022
Report Format: PDF

Download Free Sample

Demulcent Eye Drops Market Share

Firms like

Johnson and Johnson Services Inc.
Alcon Inc.
OASIS Medical
Allegan (AbbVie Inc.)
Prestige Consumer Healthcare Inc.
Santen Pharmaceutical Co. Ltd.
Bausch Health Companies Inc.
Aurolab
Otsuka Pharmaceutical Co.,Ltd.
Sentiss Pharma Pvt. Ltd.
Sun Pharmaceutical Industries Ltd.
URSAPHARM Arzneimittel GmbH

are the major competitors in the demulcent eye drops market.

In order to establish a strong market position, the manufacturers are strategically focusing on creating innovative solutions to meet the requirements of the customers. For instance, in January 2022, Systane Complete Preservative-Free Lubricant Eye Drops was made available in Europe by Alcon. This strategy widened Alcon's footprint in the massive and rapidly expanding artificial tears industry, generating sales worth over USD 1 billion annually.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for demulcent eye drop was valued at over USD 1.8 billion in 2021 and is predicted to rise at a CAGR of over 6% through 2030, owing to an increase in the incidence rate of eye ailments worldwide.

The polyols segment was valued over USD 550 million in 2021 and will exhibit a significant growth during the forecast period, owing to its usage for treatment of digital eye strain, retinal diseases, and other eye conditions.

The non-preservative-based formulation segment held a sizable market share in 2021 and is projected to surpass USD 1 billion by 2030, owing to its increasing usage resulting from growing awareness of the eye-health risks caused by preservatives.

Top enterprises such as Johnson and Johnson Services Inc., Alcon Inc., OASIS Medical, Allegan (AbbVie Inc.), Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co. Ltd., Bausch Health Companies Inc., Aurolab, and others form the competitive landscape of the global demulcent eye drops market.